Axial Therapeutics Announces Completion of Enrollment in Global Phase 2b Clinical Trial for AB-2004 for Irritability Associated with Autism
September 26, 2023 08:00 ET
|
Axial Therapeutics
– Topline clinical data anticipated in 1Q 2024 – – First-in-class small molecule therapeutic targets the microbiome gut-brain axis and its role in autism, offering a potential alternative to...
Baylor Genetics Announces Neurodevelopmental Disorders Test Panel to Help Healthcare Providers Diagnose Patients with Intellectual Disabilities or Developmental Delays
September 12, 2023 08:00 ET
|
Baylor Genetics
HOUSTON, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced the availability of a new Neurodevelopmental...
Celebrate a New Sesame Street Friend with My Friend Julia: A Sesame Street® Book about Autism by Jennifer Cook
September 07, 2023 12:08 ET
|
Lerner Publishing Group
Minneapolis, Minnesota, Sept. 07, 2023 (GLOBE NEWSWIRE) -- This September, Lerner Publications™, an imprint of Lerner Publishing Group™, presents My Friend Julia: A Sesame Street® Book about Autism...
Hopebridge Autism Therapy Centers celebrates school-readiness graduations for children across the country
August 28, 2023 09:00 ET
|
Hopebridge
Indianapolis, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Hundreds of children with autism spectrum disorder (ASD) are prepared to start school this year after graduating from Hopebridge Autism Therapy...
Autism: Is This a Vascular Disease and Would Therapeutic Angiogenesis Be a Potential Treatment?
August 15, 2023 08:00 ET
|
Zhittya Genesis Medicine Inc
LAS VEGAS, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Dr. Jack Jacobs, Chief Science Officer of Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya”), will be presenting at the online AutismOne...
Verbal Beginnings to Open New Early Intervention Comprehensive Autism Services Center in Frederick, MD
August 09, 2023 09:00 ET
|
Verbal Beginnings
FREDERICK, Md., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Verbal Beginnings, a leading provider of comprehensive Autism services is thrilled to announce the opening of a new location in Frederick, Maryland,...
PharmAla Received Guidance on ALA-002 from MHRA; Launches Clinical Program with University of Sydney
July 20, 2023 09:07 ET
|
PharmAla Biotech
VANCOUVER, British Columbia, July 20, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF), a biotechnology company focused on the research,...
SciSparc to Commence Its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder
July 14, 2023 07:55 ET
|
SciSparc Ltd
“We hope the outcome of this trial will enable the Company to procced with commercialization process for SCI-210 in Israel" TEL AVIV, Israel, July 14, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd....
Joshin Delivers Pioneering Inclusive Support Program to Tyson Foods
June 28, 2023 09:00 ET
|
Joshin
MINNEAPOLIS, June 28, 2023 (GLOBE NEWSWIRE) -- Joshin, a company that provides comprehensive solutions for disability and neurodivergence support in the workplace, today announced it is expanding...
PaxMedica CEO Interviewed by The BRAIN Foundation
June 20, 2023 08:30 ET
|
PaxMedica, Inc.
Webcast Link Available at PaxMedica.com TARRYTOWN, NY, June 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – PaxMedica, Inc. (Nasdaq: PXMD), a clinical stage biopharmaceutical company focusing on...